Popular Articles

Canadians Watch U.S. Reform Effort Closely
American health care reform has become a "hot topic north of the border," the Washington Times reports. "If Mr. Obama succeeds, the U.S. could draw even more Canadian doctors and nurses to the U.S., exacerbating a shortage of medical professionals, said Dr. Brian Day, a Canadian health care critic and former head of the Canadian Medical Association. If Mr. Obama fails, perhaps Canada could open its system to "medical tourism" from the U.S., Dr. Day said." Under the Canadian system, everyone is insured and has "access to basic health care without ever seeing a doctor or hospital bill." But 70% of Canadians also have "some form of supplemental health insurance," in part because of long wait times for tests and treatments under the government plan. For Canadian citizens who become ill in the U.S., it is often cheaper to "ride on a private Lear jet back to Canada" than to be treated in a U.S. hospital.
generic viagra online
Association Between Blood Transfusions And Infection
A study of almost 25,000 coronary artery bypass graft (CABG) patients has shown that receiving blood from another person is associated with a two-fold increase in post-operative infection rates. The research, published in the open access journal BMC Medicine, also found considerable hospital variation in transfusion practices.
News of the day
Encouraging People To Sit Less And Eat Better Through Workplace E-Mail Intervention Program
An e-mail intervention program is an effective way to significantly improve diet and physical activity by helping people move more, sit less, and make healthier food choices, according to a Kaiser Permanente Division of Research study in the American Journal of Preventive Medicine.
Diagnostics

Comparative Effectiveness Necessary To Weigh New Drugs Against Old Ones, Opinion Piece Says

Patients and physicians "need to know not just whether a new drug outperforms a placebo, but whether it"s a real advance on what"s already on the market," Richard Friedman, a professor of psychiatry at Weill Cornell Medical College, writes in a New York Times opinion piece. According to Friedman, "Doctors and patients alike are inundated by drug company marketing." Friedman states he has seen "scores of patients" who are "eager to get the latest antidepressant or mood stabilizer that promised them tranquility on their TV screens." He continues that these new treatments are not necessarily better than older, proven treatments. Comparative effectiveness research would allow "head-to-head trials comparing new and standard treatments," which is why the practice has "provoked strong resistance from the makers of drugs and devices who fear that their fancy new products may not be any better than current ones," according to Friedman. He concludes, "I"d opt for an old drug with a known track record of efficacy and safety over an expensive newcomer with no added benefit -- any day of the week" (Friedman, New York Times, 5/19). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):